December 15, 2014
LAKEWOOD, Colo., USA--December 15, 2014--The Government of Ghana has endorsed a project proposed through the collaboration of AABB, Global Blood Fund (GBF) and Terumo BCT to respond to the emerging Ebola crisis within West Africa, as well as provide long-term health system capacity to the citizens of Ghana.
Within the Southern Area Blood Centre of the NBSG a regional apheresis training center will be established as a center of excellence for other countries interested in strengthening their transfusion medicine operations. The training center will use:
"We are pleased to confirm the endorsement of the Ghanaian Ebola Readiness and Resilience Initiative. We believe this project will serve to respond to the emerging Ebola crisis within West Africa, as well as provide long-term health system capacity to the citizens ofGhana. The Ministry of Health thanks Global Blood Fund and its collaborating partners AABB and Terumo BCT for developing and proposing this activity that will benefit the people of Ghana long after we have defeated Ebola."
"This represents a unique opportunity for NBSG and the people of Ghana to leverage technology to provide for long-term health system capacity while expanding our reputation in the region as a centre of excellence in the discipline of blood transfusion. The donation of equipment and training resources will help immensely, not only with this immediate crisis, but with future challenges to public health."
"At AABB, our mission is to advance the practice and standards of transfusion medicine and cellular therapies to optimize patient and donor care and safety. This type of partnership supports an effective and collaborative approach in addressing a large and complex global challenge. Being able to share best practices, training and tools with our colleagues in West Africa, which can improve their transfusion capabilities, means that we can put in place effective, longstanding measures that will stop the spread of this disease."
"We are excited to be working in collaboration and partnership on this critical public health intervention. As an international, charitable organization, our focus is on saving lives by improving the availability and safety of blood in some of the world's poorest nations. The strength of Ghana's medical delivery system, its strong public service infrastructure and its close proximity to the current Ebola outbreak makes it a prime target for the precautionary interventions we are putting in place."
"Global blood safety is our priority. Our support of this effort is tied to our vision as an organization--Working Together for Better Lives--and demonstrates what is possible when people come together with a common goal and are willing to leverage their technology, innovation and best practices to improve people's lives. For us, that is what it is all about: the patients we ultimately serve and how our technology can make that life-saving difference. We are excited about this collaboration and look forward to working with our partners, the Republic of Ghana, AABB and Global Blood Fund on this important initiative."
Formed from the merger of the British colony of the Gold Coast and the Trust Territory of Togoland, Ghana, in 1957, became the first sub-Saharan county in colonial Africa to gain its independence. Ghana has been a stable constitutional democracy since 1992. The culturally diverse population consists of over 75 ethnic groups and enjoys considerable religious and press freedom. The Ghanaian economy, which achieved lower middle-income status in 2011, is driven primarily by agriculture, services, tourism and export of natural resources including gold, cocoa and oil. Ghana currently heads the Economic Community of West African States (ECOWAS).
The National Blood Service, Ghana (NBSG) is one of the newest Agencies under the Ministry of Health that contributes significantly to the implementation of the Health Sector Programmes of action. NBSG provides an essential service within Ghana and aspires to be rated amongst the best in the world in the provision of blood and blood products, as well as in relation to the research and training provided. Our key purpose is to save patients' lives. For more information, visit www.nbsghana.org.
AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership consists of nearly 2,000 institutions and 8,000 individuals, including physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. Members are located in more than 80 countries. For more information, visit http://www.aabb.org.
Global Blood Fund is a not-for-profit charity established in 2008 run by practicing professionals working in blood donation management in the U.S. and Europe who are appalled by the huge global inequalities in access to safe blood. Our aim is to save lives by improving the availability and safety of blood in some of the world's poorest nations. We focus on enabling blood services in developing countries to nurture that most precious of resources -- their blood donors. In rich places and poor, the people that freely give their blood are the cornerstone of a plentiful supply of safe blood. GBF has provided money, equipment and other forms of support to countries in Africa, Asia, the Caribbean and South America. For more information visit www.globalbloodfund.org
Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers. For more information, visit www.terumobct.com.
(Notice) Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition. The market share information in this press release is partly derived from our own independent research.